Tianjin, China —November, 2025

Tasly Group is pleased to announce its official collaboration with STEMCELL-2026, an international conference dedicated to advancing global dialogue and innovation in stem cell research and regenerative medicine.

As one of China’s leading life science enterprises, Tasly Group has long been committed to integrating traditional wisdom with cutting-edge biotechnology to promote human health and longevity. Through this partnership, Tasly aims to further strengthen international scientific exchange and contribute to the global development of stem cell and regenerative medicine industries.

The STEMCELL-2026 Conference will bring together renowned scientists, clinicians, and industry leaders from around the world to discuss the latest breakthroughs, translational strategies, and emerging trends in stem cell science. As an official collaborator, Tasly Group will actively support the conference’s mission of fostering academic collaboration, innovation, and ethical progress in life sciences.

“Global partnerships are vital to accelerating scientific advancement,” said a Tasly spokesperson. “By working with international organizations such as STEMCELL-2026, we hope to share our research insights, enhance cross-border collaboration, and help translate cutting-edge technologies into real-world health solutions.”

For more information about STEMCELL-2026, please visit https://stemcells.pagesconferences.org.